Maynard Um
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Silence Therapeutics (SLN): "looks cheap at $175M+ EV"
-
-
-
-
-
-
-
Silence Therapeutics (SLN) PT Lowered to $45 at Morgan Stanley
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN)
-
-
-
-
-
-
-
Silence Therapeutics (SLN) to Receive $2M Cash Milestone from Hansoh Pharma
-
-
-
432,729 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

